Proteasome inhibitors in myocardial ischemia, some concerns.
Powell
Saul R
SR
D000111:Acetylcysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D051379:Mice; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000503:physiopathology; D016328:NF-kappa B / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D061988:Proteasome Inhibitors; D015427:Reperfusion Injury / Q000517:prevention & control*; D012307:Risk Factors; D012680:Sensitivity and Specificity
D016328:NF-kappa B; C411422:PS519; D061988:Proteasome Inhibitors; D046988:Proteasome Endopeptidase Complex; D000111:Acetylcysteine